Novel initiation genes in squamous cell carcinomagenesis: A role for substrate-specific ubiquitylation in the control of cell survival

Molecular Carcinogenesis

Volumn 46, Issue 8, 2007, Pages 585-590

  Albor, Amador ^a   Kulesz Martin, Molly ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Carcinogenesis; E3 ubiquitin ligase; Piasy; Protein degradation; Trim family scaffold proteins

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN PIASY; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER MODEL; CELL LINEAGE; CELL SURVIVAL; CONFERENCE PAPER; EPIDERMIS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; HUMAN; KERATINOCYTE; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SENESCENCE; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TRIM32 GENE; UBIQUITINATION; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; NF-KAPPA B; PROTEIN INHIBITORS OF ACTIVATED STAT; SKIN NEOPLASMS; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 34547916840     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20344     Document Type: Conference Paper

References (21)

1. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of "single protein RING finger" E3 ubiquitin ligases. Bioessays 2005;27:1147-1157.
2. Horn EJ, Albor A, Liu Y, et al. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 2004;25:157-167.
3. Albor A, El Hizawi S, Horn EJ, et al. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB. J Biol Chem 2006;281:25850-25866.
4. Kulesz-Martin MF, Penetrante R, East CJ. Benign and malignant tumor stages in a mouse keratinocyte cell line treated with 7,12-dimethylbenz[α] anthracene in vitro. Carcinogenesis 1988;9:171-174.
5. Schneider BL, Bowden GT, Sutter C, Schweizer J, Han KA, Kulesz-Martin MF. 7,12-Dimethylbenz[a]anthracene-induced mouse keratinocyte malignant transformation independent of Harvey ras activation. J Invest Dermatol 1993;101:595-599.
6. Knights CD, Liu Y, Appella E, Kulesz-Martin M. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification. J Biol Chem 2003;278:52890-52900.
7. Wang Z, Liu Y, Mori M, Kulesz-Martin M. Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates. Carcinogenesis 2002;23:635-643.
8. Kudryashova E, Kudryashov D, Kramerova I, Spencer MJ. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J Mol Biol 2005;354:413-424.
9. Frosk P, Weiler T, Nylen E, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 2002;70:663-672.
10. Chiang AP, Beck JS, Yen HJ, et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci USA 2006;103:6287-6292.
11. Mabb AM, Wuerzberger-Davis SM, Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol 2006;8:986-993.
12. Bischof O, Schwamborn K, Martin N, et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 2006;22:783-794.
13. Ohmine K, Ota J, Ueda M, et al. Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Oncogene 2001;20:8249-8257.
14. Wong KA, Kim R, Christofk H, Gao J, Lawson G, Wu H. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol Cell Biol 2004;24:5577-5586.
15. Roth W, Sustmann C, Kieslinger M, et al. PIASy-deficient mice display modest defects in IFN and Wnt signaling. J Immunol 2004;173:6189-6199.
16. Zhuang L, Wang B, Shinder GA, Shivji GM, Mak TW, Sauder DN. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 1999;162:1440-1447.
17. Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand. J Invest Dermatol 2001;117:898-907.
18. Karin M. NF-kappaB and cancer: mechanisms and targets. Mol Carcinog 2006;45:355-361.
19. Kobielak A, Fuchs E. Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci USA 2006;103:2322-2327.
20. Chung CH, Parker JS, Ely K, et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-{kappa}B signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 2006;66:8210-8218.
21. Duffey DC, Crowl-Bancroft CV, Chen Z, et al. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death. Br J Cancer 2000;83:1367-1374.